About this trial
This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.
Eligibility criteria
Qualifiers
Consecutive adult patients (18 yrs. of age or older)
Disqualifiers
Endovascular embolization of middle meningeal artery using any other embolization material
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Montefiore Medical Center
Lead sponsor
Geisinger Clinic
Collaborator
Heidelberg University
Collaborator
Henri Mondor University Hospital
Collaborator
Ospedale Policlinico San Martino
Collaborator
Ospedale San Raffaele
Collaborator
Lehigh Valley Hospital
Collaborator
Mayo Clinic
Collaborator
Medical University of South Carolina
Collaborator
New York University
Collaborator
Oregon Health and Science University
Collaborator
Sisters of Mercy University Hospital
Collaborator
Unity Health Toronto
Collaborator
Sutter Health
Collaborator
University of Iowa
Collaborator
Thomas Jefferson University
Collaborator
University Health Network, Toronto
Collaborator
University Hospital, Bordeaux
Collaborator
University of Alabama at Birmingham
Collaborator
University of South Florida
Collaborator
University of Washington
Collaborator
Cornell University
Collaborator
Westchester Medical Center
Collaborator